Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 160

The DOI matches its Crossref record.

Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia

Open access
Craddock, Charles, Jackson, Aimee, Loke, Justin, Siddique, Shamyla, Hodgkinson, Andrea, Mason, John, Andrew, Georgia, Nagra, Sandeep, Malladi, Ram, Peniket, Andrew, Gilleece, Maria, Salim, Rahuman, Tholouli, Eleni, Potter, Victoria, Crawley, Charles, Wheatley, Keith, Protheroe, Rachel, Vyas, Paresh, Hunter, Ann, Parker, Anne, Wilson, Keith, Pavlu, Jiri, Byrne, Jenny, Dillon, Richard, Khan, Naeem, McCarthy, Nicholas, Freeman, Sylvie D. · 2021 · Journal of Clinical Oncology

Abstract

PURPOSE: Reduced-intensity conditioning (RIC) regimens have extended the curative potential of allogeneic stem-cell transplantation to older adults with high-risk acute myeloid leukemia (AML) and myelodysplasia (MDS) but are associated with a high risk of disease relapse. Strategies to reduce recurrence are urgently required. Registry data have demonstrated improved outcomes using a sequential transplant regimen, fludarabine/amsacrine/cytarabine-busulphan (FLAMSA-Bu), but the impact of this intensified conditioning regimen has not been studied in randomized trials. PATIENTS AND METHODS: Two hundred forty-four patients (median age, 59 years) with high-risk AML (n = 164) or MDS (n = 80) were randomly assigned 1:1 to a fludarabine-based RIC regimen or FLAMSA-Bu. Pretransplant measurable residual disease (MRD) was monitored by flow cytometry (MFC-MRD) and correlated with outcome. RESULTS: There was no difference in 2-year overall survival (hazard ratio 1.05 [85% CI, 0.80 to 1.38] P = .81) or cumulative incidence of relapse (CIR) (hazard ratio 0.94 [95%CI, 0.60 to 1.46] P = .81) between the control and FLAMSA-Bu arms. Detectable pretransplant MFC-MRD was associated with an increased CIR (2-year CIR 41.0% v 20.0%, P = .01) in the overall trial cohort with a comparable prognostic impact when measured by an unsupervised analysis approach. There was no evidence of interaction between MRD status and conditioning regimen intensity for relapse or survival. Acquisition of full donor T-cell chimerism at 3 months abrogated the adverse impact of pretransplant MRD on CIR and overall survival. CONCLUSION: The intensified RIC conditioning regimen, FLAMSA-Bu, did not improve outcomes in adults transplanted for high-risk AML or MDS regardless of pretransplant MRD status. Our data instead support the exploration of interventions with the ability to accelerate acquisition of full donor T-cell chimerism as a tractable strategy to improve outcomes in patients allografted for AML.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.20.02308

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 160

Metadata

Authors
Craddock, C., Jackson, A., Loke, J., Siddique, S., Hodgkinson, A., Mason, J., Andrew, G., Nagra, S., Malladi, R., Peniket, A., Gilleece, M., Salim, R., Tholouli, E., Potter, V., Crawley, C., Wheatley, K., Protheroe, R., Vyas, P., Hunter, A., Parker, A., Wilson, K., Pavlu, J., Byrne, J., Dillon, R., Khan, N., McCarthy, N., & Freeman, S. D.
Venue
Journal of Clinical Oncology
Published
2021-03-01
Volume
39
Issue
7
Pages
768-778
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W3115439304
Cited by
160
References
0
FWCI
11.48
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia. https://app.cochat.ai/papers/10.1200/jco.20.02308
The paper
Craddock, C., Jackson, A., Loke, J., Siddique, S., Hodgkinson, A., Mason, J., Andrew, G., Nagra, S., Malladi, R., Peniket, A., Gilleece, M., Salim, R., Tholouli, E., Potter, V., Crawley, C., Wheatley, K., Protheroe, R., Vyas, P., Hunter, A., . . . Freeman, S. D. (2021). Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia. Journal of Clinical Oncology. https://doi.org/10.1200/jco.20.02308

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.